In the case of CYP4F3, the findings included its emergence as a progression marker in bladder cancer, modulated by calcitriol in cervical cancer; it was also associated with poor prognosis in colorectal liver metastasis and included in a prognostic model of endometrial cancer. Here, CYP4F3 is linked to endometrial cancer.